Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
Ultrasound is routinely used to screen for HCC. However, its utility is limited by numerous factors, including patient body habitus, operator experience and certain liver conditions, all of which contribute to decreases in sensitivity.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
Behind every successful PACS is a carefully orchestrated storage strategy - and hardware and software storage vendors made this quite apparent at this year's RSNA show.
PerkinElmer Optoelectronics introduced a new high-intensity xenon fiber optic illumination system that can be customized for a variety of medical OEM applications such as endoscopy and surgical headlamps that require bright, accurate color illumination.
Eclipsys Corp. this week said it has completed the acquisition of eSys Medical Systems Inc., a radiology information system (RIS) company headquartered in Montreal, Canada.
NEMA, the National Electrical Manufacturers Association, this week released a 16-part update of the Digital Imaging and Communications in Medicine (DICOM) standard.
The American Society for Therapeutic Radiology and Oncology (ASTRO) has published seven patient information brochures that explain how radiation therapy is used to safely and effectively treat various cancers.
Medical imaging components manufacturer Dunlee introduced at this year's RSNA Glassware Solutions, a new program for predicting and managing glassware replacement.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
